REG - Fortis Frontier PLC - Executive Chairman buys 50,000 shares

Fortis FrontierAnnouncement

05/01/2026 13:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260105:nRSE6893Na&default-theme=true

RNS Number : 6893N  Fortis Frontier PLC  05 January 2026

 

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

 

Executive Chairman buys 50,000 shares

 

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly
MyHealthChecked PLC), announces that it was notified that on 5 January 2026
that Adam Reynolds, Executive Chairman, purchased a total of 50,000 (fifty
thousand) ordinary shares of 1.5 pence each in the Company ("Ordinary Shares")
at a price of 8.5 pence per Ordinary Share. Following this transaction, Adam
Reynolds' total direct and indirect interest in the Company is 750,886
Ordinary Shares representing approximately 1.44% of the Company's total issued
share capital.

 

The Notification of Dealing Form required in accordance with UK MAR is set out
below.

 

In addition, Adam Reynolds has also surrendered options over 66,667 ordinary
shares granted on 28 July 2021, with an exercise price of 52.5p for nil
consideration.

 

For further information contact:

 

 Fortis Frontier PLC                                                              www.fortisfrontierplc-ir.com (http://www.fortisfrontierplc-ir.com)
 Adam Reynolds, Executive Chairman                                                via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)                                          Tel: +44 (0)20 3368 3550
 Neil Baldwin

 Dowgate Capital Limited (Broker)                        Tel: +44 (0)20 3903 7715
 David Poutney / Russell Cook

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com
                                   (mailto:fortisfrontier@walbrookpr.com)
 Paul McManus / Alice Woodings                           Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

 

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading
subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell,
as defined in the AIM Rules for Companies. On the same day the Company changed
its name to Fortis Frontier PLC. The Board is now carefully considering the
strategic options available to it in order to maximise shareholder value.

 

 1    Details of the person discharging managerial responsibilities / person closely
      associated

 a)   Name                                                         Adam Reynolds

 2    Reason for the notification

 a)   Position/status                                              Executive Chairman
 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction
      platform, auctioneer or auction monitor

 a)   Name                                                         FORTIS FRONTIER PLC
 b)   LEI                                                          213800RBHY6LZDG13168

 4    Details of the transaction(s): section to be repeated for (i) each type of
      instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares

      Identification code                                          ISIN: GB00BYZ2R301

 b)   Nature of the transaction                                    Purchase of Ordinary Shares
 c)   Price(s) and volume(s)

                                                                                         Price(s)              Volume(s)
                                                                                         8.5 pence             50,000

 d)   Aggregated information

      - Aggregated volume                                          N/A - Single Transaction

      - Price

 e)   Date of the transaction                                      5 January 2026

 f)   Place of the transaction                                     London Stock Exchange - AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBXGDBCDGDGLU



            Copyright 2019 Regulatory News Service, all rights reserved